General Category > NF2
NF2 clinical trial at MGH
(1/1)
Susan A:
Dr Plotkin at Mass General Hospital is starting a new Phase 2 clinical trial for people with NF2. The goal of this clinical research study is to learn if the study drug AZD2014 can shrink growing or symptomatic meningiomas.
mwatto:
https://www.nature.com/articles/s41598-020-60156-6
Navigation
[0] Message Index
Go to full version